These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. Octreotide treatment of carcinoid hypertensive crisis. Warner RR; Mani S; Profeta J; Grunstein E Mt Sinai J Med; 1994 Sep; 61(4):349-55. PubMed ID: 7969229 [TBL] [Abstract][Full Text] [Related]
51. [Symptomatic treatment of the malignant carcinoid syndrome with octreotide]. Alberts AS; Falkson G S Afr Med J; 1989 Jan; 75(1):30-1. PubMed ID: 2911781 [TBL] [Abstract][Full Text] [Related]
52. Comparison of Octreotide and Vasopressors as First-Line Treatment for Intraoperative Carcinoid Crisis. Ammann M; Kinney MAO; Gudmundsdottir H; Santol J; Thiels CA; Warner SG; Truty MJ; Kendrick ML; Smoot RL; Anderson AL; Halfdanarson TR; Nagorney DM; Starlinger PP Ann Surg Oncol; 2024 Jun; 31(6):3976-3977. PubMed ID: 38619707 [No Abstract] [Full Text] [Related]
53. Serotonin in cytologic samples of liver metastases of carcinoid tumors. An immunocytochemical study with a monoclonal antibody. Wilander E Acta Cytol; 1985; 29(6):1058-60. PubMed ID: 3866458 [TBL] [Abstract][Full Text] [Related]
54. Bronchial carcinoid tumor presenting as a thyroid nodule: an unusual clinical manifestation. Chico A; Pallarés MC; Matías-Guiu X; Ciprés L; Puig-Domingo M; Webb SM J Endocrinol Invest; 1996 Mar; 19(3):186-9. PubMed ID: 8743286 [TBL] [Abstract][Full Text] [Related]